Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04360824 · ClinicalTrials.gov registry record · Phase 4
Covid-19 Associated Coagulopathy
A Phase 4 study, sponsored by University of Iowa.
- Completed
- Registry status
- Phase 4
- Development phase
- 176
- Enrollment target
NCT04360824: Completed Phase 4 study, sponsored by University of Iowa.
NCT04360824 is a Phase 4 study that has completed, run by University of Iowa. The registered enrollment target is 176 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (66% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04360824, a Phase 4 study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 176 participants
- Enrollment target
Study Summary
This prospective, randomized, open-label, multi-center interventional study is designed to compare the safety and efficacy of two LMWH dosing protocols in patients admitted to the University of Iowa Hospitals with COVID-19 who meet the modified ISTH Overt DIC criteria score ≥3. Patients will be randomized to standard prophylactic dose LMWH (standard of care arm) or intermediate-dose LMWH (intervention arm).
Primary Outcome
All-cause mortality
Interventions
- DRUG Intermediate dose thromboprophylaxis
- DRUG Standard of Care thromboprophylaxis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2020-05-06 |
| Est. Completion | 2021-04-16 |
| Phase | Phase 4 |
What the finished NCT04360824 record still lists
NCT04360824 is an interventional study that assigns participants to a tested intervention. The registered 176 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (66% lower).
The record links to 0 conditions, and to 2 interventions - of which Intermediate dose thromboprophylaxis is the first listed.
NCT04360824 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04360824 about?
NCT04360824 is a clinical study titled "Covid-19 Associated Coagulopathy". This prospective, randomized, open-label, multi-center interventional study is designed to compare the safety and efficacy of two LMWH dosing protocols in patients admitted to the University of Iowa Hospitals with COVID-19 who meet the modified ISTH Overt DIC criteria score ≥3. Patients will be rand...
What is the current status of trial NCT04360824?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 176 participants. The study started on 2020-05-06. Estimated completion is 2021-04-16.
What interventions are being tested in trial NCT04360824?
The interventions under investigation include: Intermediate dose thromboprophylaxis (DRUG), Standard of Care thromboprophylaxis (DRUG).
Who is sponsoring clinical trial NCT04360824?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04360824's enrollment target sits among peer trials
176 477th of 2000 higher than 1,523 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03304821 · 176 participants · Phase 2
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
- NCT03447938 · 176 participants · NA
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
- NCT03824145 · 176 participants · NA
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
- NCT04177914 · 176 participants · Phase 3
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI